Characterization of protein cargo of Echinococcus granulosus extracellular vesicles in drug response and its

María Celeste Nicolao1,2, Christian Rodriguez Rodrigues2,3, Magalí B Coccimiglio1

  • 1Laboratorio de Zoonosis Parasitarias, IIPROSAM, Universidad Nacional de Mar del Plata (UNMdP), Funes 3350, Nivel Cero, 7600, Mar del Plata, Argentina.

Parasites & Vectors
|July 29, 2023
PubMed
Abstract

Insights

Small extracellular vesicles (sEVs) from drug-treated Echinococcus granulosus protoscoleces modulate immune responses. These parasite-derived sEVs enhance dendritic cell activation, suggesting a novel approach for treating echinococcosis.

Area of Science:

  • Parasitology
  • Immunology
  • Extracellular Vesicle Biology

Background:

  • Cystic echinococcosis is a significant zoonotic disease caused by Echinococcus granulosus.
  • Parasite-derived small extracellular vesicles (sEVs) play a role in host-parasite interactions and disease progression.
  • The impact of sEVs from drug-treated parasites on host immune responses remains largely unknown.

Purpose of the Study:

  • To investigate the characteristics and immunomodulatory effects of sEVs isolated from Echinococcus granulosus protoscoleces treated with drugs.
  • To analyze the protein cargo of sEVs and their influence on dendritic cell cytokine production.

Main Methods:

  • Isolation and characterization of sEVs from control and drug-treated protoscoleces using ultracentrifugation, electron microscopy, dynamic light scattering, and proteomic analysis.
  • Evaluation of cytokine profiles in murine bone marrow-derived dendritic cells (BMDCs) exposed to sEVs via qPCR.

Main Results:

  • sEVs, irrespective of drug treatment, contained over 500 cargo proteins, including known and potential antigens.
  • Proteomic analysis revealed drug-specific proteins in sEVs from metformin- and albendazole sulfoxide (ABZSO)-treated parasites.
  • sEVs from treated parasites, particularly metformin, significantly altered cytokine expression in BMDCs, promoting pro-inflammatory responses (IL-12, IL-6, TNF-α) while downregulating others (IL-23, TGF-β).

Conclusions:

  • sEVs derived from drug-treated Echinococcus granulosus protoscoleces possess immunomodulatory functions.
  • These sEVs can enhance dendritic cell activation towards a type 1 pro-inflammatory profile.
  • This finding supports the development of novel therapeutic strategies for secondary echinococcosis.